Search
Now showing items 1-10 of 40
Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
Fink, Anna Maria et al. (2017)
Wissenschaftlicher Artikel
Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group
Al-Sawaf, Othman et al. (2017)
Wissenschaftlicher Artikel
Azacitidine in adult patients with acute myeloid leukemia
Schuh, Andre C. et al. (2017)
Wissenschaftlicher Artikel
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
Kroenke, J. et al. (2017)
Wissenschaftlicher Artikel
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
Wattad, M. et al. (2017)
Wissenschaftlicher Artikel
Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes
Bohl, Stephan R. et al. (2017)
Wissenschaftlicher Artikel
Improved OutcomesWith Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
Platzbecker, Uwe et al. (2017)
Wissenschaftlicher Artikel
RUNX1 mutations in acute myeloid leukemia
Teleanu, Maria-Veronica (2017)
Dissertation
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Pleyer, Lisa et al. (2017)
Wissenschaftlicher Artikel
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Jaramillo, S. et al. (2017)
Wissenschaftlicher Artikel